Unlock instant, AI-driven research and patent intelligence for your innovation.

Application of nanobody I22 to detection of recombinant human interferon alpha 2b

A technology of recombinant human interferon and nano-antibody, which is applied in the direction of measuring devices, biological testing, material inspection products, etc., can solve the problems of unfavorable rapid detection, lack of research, and reduce production costs, so as to achieve rapid detection, accurate experimental results, The effect of reducing production costs

Inactive Publication Date: 2019-09-17
NAT INST FOR FOOD & DRUG CONTROL
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

This method has a long cycle, high cost, batch differences between antibodies, and the whole process requires low-temperature transportation and storage, which is not conducive to rapid detection
The nanobody I22 screened out by the Chinese patent "an anti-interferon α-2b nanobody and its application" (application number 201710965143.X, publication number CN107857816A, publication date 2018.03.30) is produced using a prokaryotic expression system, reducing the Production cost, the whole process does not require cold chain transportation, and has high stability, high specificity, small molecular weight and large-scale production. However, there is still a lack of further research on its use in the detection of recombinant human interferon α2b, so it is not yet available. Clinical application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of nanobody I22 to detection of recombinant human interferon alpha 2b
  • Application of nanobody I22 to detection of recombinant human interferon alpha 2b
  • Application of nanobody I22 to detection of recombinant human interferon alpha 2b

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0046] Embodiment 1: Construction of expression system

[0047]The screened target protein anti-recombinant human interferon α2b nanobody I22 gene sequence was constructed into the vector pET28a, and pET28a-His-I22-His with His tags at the N-terminal and C-terminal was constructed. The enzyme cutting site of this strain vector is NcoI / XHoI, such as figure 1 .

Embodiment 2

[0048] Example 2: Induced Expression Purification

[0049] In the first step, the nanobody I22 expression vector pET28a-His-I 22 -His were transformed into BL21 host bacteria respectively.

[0050] In the second step, the bacterial culture medium was placed in LB / Kan liquid medium (containing 1 mM IPTG), and the expression was induced in a shaker at 16° C. at 220 rpm.

[0051] In the third step, after 13 hours, centrifuge at 4°C and 13,000 rpm for 28 minutes to collect the bacterial liquid precipitate. Suspend the precipitate with an equilibration buffer, sonicate, centrifuge at 13,000 rpm at 4°C for 26 minutes, and collect the supernatant.

[0052] In the fourth step, use the nickel column to purify the protein, use the original bacterial solution as a positive control, and obtain a single target band at about 15kDa, which is the target protein, such as figure 2 .

[0053] The fifth step is to test the purity of the purified target protein and analyze the quality of the ...

Embodiment 3

[0055] Example 3: Whole-column imaging isoelectric focusing capillary electrophoresis to measure the isoelectric point of nanobody I22 protein

[0056] The first step is to prepare the solution, prepare positive electrolyte (85% phosphoric acid solution) and negative electrolyte (50% NaOH solution), 1% methylcellulose solution, and 8mol / L urea solution.

[0057] In the second step, the sample determination solution was thoroughly mixed, taking 2 μL each of Marker pI=4.65 and pI=8.96, 140 μL of 1% methylcellulose (methylcellulose), 25 μL of 8M Urea solution, and a total volume of 169 μL.

[0058] The third step is the preparation of samples and standards. Concentrate the protein sample to about 4 mg / mL, take 5 μL, mix it with 169 μL of measurement solution, and make up to 200 μL with deionized water.

[0059] In the fourth step, the sample is degassed, and the sample solution is centrifuged for 3 minutes at a speed of 11,000 rpm, quantitatively transferred to an automatic sampl...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention relates to application of a nanobody I22 to detection of a recombinant human interferon alpha 2b. A series of experiment researches prove that in the detection of the recombinant human interferon alpha 2b, the nanobody I22 is more sensitive than a commercial monoclonal antibody; the nanobody I22 is combined with a colloidal gold labeling technique; and a detection limit of detecting the recombinant human interferon alpha 2b can reach 1 [mu]g / mL. An colloidal gold test strip developed for the first time implements rapid detection, an immune identification test originally consuming two days is shortened into rapid detection completed in a couple of minutes, and primary application of rapid detection on the recombinant human interferon alpha 2b is implemented.

Description

technical field [0001] The invention relates to the detection of the recombinant human interferon α2b by the nanobody, in particular the realization of the rapid detection application of the nanobody to the recombinant human interferon α2b. Background technique [0002] my country is a big country with frequent hepatitis. Recombinant human interferon is currently internationally recognized as an effective drug for treating hepatitis. For gene recombinant drugs, the quality control of drugs is the focus of our attention, and the identification test of drugs is the main basis for qualitative testing of drugs. [0003] For recombinant human interferon, according to the third part of the "Chinese Pharmacopoeia" 2015 edition, the identification experiment of recombinant human interferon α2b products was carried out, mainly using immunological detection methods (immunoblotting or immunoblotting). This method has a long cycle, high cost, batch differences between antibodies, and t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N33/68G01N33/58
CPCG01N33/6866G01N33/583
Inventor 饶春明秦玺段茂芹裴德宁周勇陶磊史新昌于雷
Owner NAT INST FOR FOOD & DRUG CONTROL